NGL Fine-Chem Limited (NSE:NGLFINE)
India flag India · Delayed Price · Currency is INR
1,284.90
-0.70 (-0.05%)
May 22, 2025, 3:15 PM IST

NGL Fine-Chem Company Description

NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for use in veterinary and human health worldwide.

The company offers animal health pharmaceutical ingredients, such as diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine hcl, s-methoprene, toltrazuril, decoquinate, amitraz, marbofloxacin, flunixin meglumine, praziquantel, carprofen, fenbendazole, and xylazine hydrochloride.

It also offers human health pharmaceutical ingredients comprising of nitazoxanide and atovaquone; and intermediates and specialty chemicals consisting of trimethyl, triazacylononane, and ethyl glucamine.

In addition, the company provides finished dosage forms comprising of diminazene aceturate granules and homidium chloride tablets.

NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.

NGL Fine-Chem Limited
Country India
Founded 1981
Industry Drug Manufacturers - General
Sector Healthcare
Employees 682
CEO Rahul Nachane

Contact Details

Address:
301, E Square
Mumbai, 400057
India
Phone 91 22 4084 2222
Website nglfinechem.com

Stock Details

Ticker Symbol NGLFINE
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE887E01022
SIC Code 2833

Key Executives

Name Position
Rahul Jayant Nachane Chief Executive Officer, MD, Chief Ethics Counsellor and Executive Director
Rajesh Narayan Lawande Whole Time Director and Chief Financial Officer
Pallavi Pednekar Company Secretary and Compliance Officer
Ahaan Nachane Vice President